Current Therapeutic Research - Clinical and Experimental

Aims & Scope

We also encourage the submission of manuscripts presenting preclinical and very preliminary research that may stimulate further investigation of potentially relevant findings, as well as in-depth review articles on specific therapies or disease states, and applied health delivery or pharmacoeconomics.

CTR encourages and supports the submission of manuscripts describing: • Interventions designed to understand or improve human health, disease treatment or disease prevention; • Studies that focus on problems that are uncommon in resource-rich countries; • Research that is "under-published" because of limited access to monetary resources such as English language support and Open Access fees (CTR offers deeply discounted English language editing); • Republication of articles previously published in non-English journals (eg, evidence-based guidelines) which could be useful if translated into English; • Preclinical and clinical product development studies that are not pursued for further investigation based upon early phase results.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,420.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease:

  Citation: 315

  Authors: George T

• Schistosomiasis: Life Cycle, Diagnosis, and Control

  Citation: 222

  Authors: Martin L.

• Viscosupplementation of osteoarthritic knees with hylan: A treatment schedule study

  Citation: 116

  Authors: D., M., W.

• Effects of Dapagliflozin on Body Composition and Liver Tests in Patients with Nonalcoholic Steatohepatitis Associated with Type 2 Diabetes Mellitus: A Prospective, Open-label, Uncontrolled Study

  Citation: 107

  Authors: Hiroshi, Shuichi, Tatsuya, Shunji, Yoshikazu

• Multicenter clinical trial of the serum lipid-lowering effects of a Monascus purpureus (red yeast) rice preparation from traditional Chinese medicine

  Citation: 105

  Authors: Junxian, Zongliang, Jiamin, Wenhua, Meizhe, Wenrong, Pulin, Lijiang, Li, Jia-Shi, Joseph

• Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey

  Citation: 95

  Authors: Adam Keller, Brenda D., Wendy, Christine

• A Revised Estimate of the Burden of Illness of Gout

  Citation: 91

  Authors: Albert, Robert, Michael A.

• Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: An open-label, pilot study in 10 pediatric patients

  Citation: 87

  Authors: Ewa, Joanna, Anna, Anna, Agnieszka, Marcelina, Barbara, Ewa, Anna, Tomasz, Sylwia, Alicja, Grzegorz

• Clinical Pharmacology of Paracetamol in Neonates: A Review

  Citation: 84

  Authors: Gian Maria, Karel

• Pill Properties that Cause Dysphagia and Treatment Failure

  Citation: 77

  Authors: Jeremy, Jorge T., Konrad S.